CAPRICOR THERAPEUTICS, INC. Payments to Acquire Marketable Securities
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Payments to Acquire Marketable Securities of $250.84 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-14
- CAPRICOR THERAPEUTICS, INC. payments to acquire marketable securities for the quarter ending 2026-06-30 was $75.95M, a 26.59% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. payments to acquire marketable securities for the quarter ending 2026-03-31 was $174.89M, a 861.92% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. payments to acquire marketable securities for the quarter ending 2025-12-31 was $15.00M, a 89.24% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. payments to acquire marketable securities for the quarter ending 2025-09-30 was $58.21M, a 194.11% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. payments to acquire marketable securities for fiscal 2025 was $151.39M, a 27.37% decline from fiscal 2024.
- CAPRICOR THERAPEUTICS, INC. payments to acquire marketable securities for fiscal 2024 was $208.44M, a 113.91% increase from fiscal 2023.
- CAPRICOR THERAPEUTICS, INC. payments to acquire marketable securities for fiscal 2023 was $97.44M, a 14.69% decline from fiscal 2022.
- CAPRICOR THERAPEUTICS, INC. payments to acquire marketable securities for fiscal 2022 was $114.22M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 6 month as first filed | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month | Payments to Acquire Marketable Securities 102 month | Payments to Acquire Marketable Securities 105 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $75.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $250.84M 10-Q · filed 2026-08-14 | $265.84M derived: sum of 3 quarters · filed 2026-08-14 | $324.06M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $174.89M 10-Q · filed 2026-05-13 | $189.89M derived: sum of 2 quarters · filed 2026-05-13 | $248.11M derived: sum of 3 quarters · filed 2026-05-13 | $308.10M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $73.21M derived: sum of 2 quarters · filed 2026-03-17 | $133.21M derived: sum of 3 quarters · filed 2026-08-14 | $151.39M 10-K · filed 2026-03-17 | |||
| 2025-09-30 | $58.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $118.21M derived: sum of 2 quarters · filed 2026-08-14 | $136.39M 10-Q · filed 2025-11-10 | $275.76M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $60.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $78.18M 10-Q · filed 2026-08-14 | $217.54M derived: sum of 3 quarters · filed 2026-08-14 | $237.34M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $18.18M 10-Q · filed 2026-05-13 | $157.55M derived: sum of 2 quarters · filed 2026-05-13 | $177.34M derived: sum of 3 quarters · filed 2026-05-13 | $193.41M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $139.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $159.16M derived: sum of 2 quarters · filed 2026-03-17 | $175.23M derived: sum of 3 quarters · filed 2026-03-17 | $208.44M 10-K · filed 2026-03-17 | |||
| 2024-09-30 | $19.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $35.87M derived: sum of 2 quarters · filed 2025-11-10 | $69.08M 10-Q · filed 2025-11-10 | $93.85M derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | $16.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $49.28M 10-Q · filed 2025-08-11 | $74.06M derived: sum of 3 quarters · filed 2025-08-11 | $93.86M derived: sum of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | $33.21M 10-Q · filed 2025-05-14 | $57.99M derived: sum of 2 quarters · filed 2025-05-14 | $77.79M derived: sum of 3 quarters · filed 2025-05-14 | $95.85M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $24.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $44.58M derived: sum of 2 quarters · filed 2025-03-26 | $62.64M derived: sum of 3 quarters · filed 2025-03-26 | $97.44M 10-K · filed 2025-03-26 | |||
| 2023-09-30 | $19.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $37.86M derived: sum of 2 quarters · filed 2024-11-14 | $72.67M 10-Q · filed 2024-11-14 | $104.71M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | $18.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $52.86M 10-Q · filed 2024-08-08 | $84.91M derived: sum of 3 quarters · filed 2024-08-08 | $118.07M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $34.80M 10-Q · filed 2024-05-14 | $66.85M derived: sum of 2 quarters · filed 2024-05-14 | $100.01M derived: sum of 3 quarters · filed 2024-05-14 | $149.02M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $32.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $65.21M derived: sum of 2 quarters · filed 2024-03-11 | $114.22M derived: sum of 3 quarters · filed 2024-03-11 | $114.22M 10-K · filed 2024-03-11 | |||
| 2022-09-30 | $33.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $82.18M derived: sum of 2 quarters · filed 2023-11-14 | $82.18M 10-Q · filed 2023-11-14 | $82.18M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $49.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $49.01M 10-Q · filed 2023-08-08 | $49.01M derived: sum of 3 quarters · filed 2023-08-08 | $49.01M derived: sum of 4 quarters · filed 2023-08-08 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-05-12 | $0.00 derived: sum of 3 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $0.00 derived: sum of 2 quarters · filed 2023-03-17 | $0.00 10-K · filed 2023-03-17 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 | ||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $0.00 derived: sum of 2 quarters · filed 2022-03-11 | $0.00 derived: sum of 3 quarters · filed 2022-03-11 | $6.13M 10-K · filed 2022-03-11 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $6.13M 10-Q · filed 2021-11-12 | $12.12M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $6.13M 10-Q · filed 2021-08-13 | $12.12M derived: sum of 3 quarters · filed 2021-08-13 | $12.12M derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $6.13M 10-Q · filed 2021-05-14 | $12.12M derived: sum of 2 quarters · filed 2021-05-14 | $12.12M derived: sum of 3 quarters · filed 2021-05-14 | $12.12M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | $5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $5.99M derived: sum of 2 quarters · filed 2021-03-15 | $5.99M derived: sum of 3 quarters · filed 2021-03-15 | $6.00M 10-K · filed 2021-03-15 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $15.24K 10-Q · filed 2020-11-13 | $3.03M derived: sum of 4 quarters · filed 2020-11-13 | |||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $15.24K 10-Q · filed 2020-08-10 | $3.03M derived: sum of 3 quarters · filed 2020-08-10 | $9.02M derived: sum of 4 quarters · filed 2020-08-10 | |||
| 2019-03-31 | $15.24K 10-Q · filed 2020-05-15 | $3.03M derived: sum of 2 quarters · filed 2020-05-15 | $9.02M derived: sum of 3 quarters · filed 2020-05-15 | $15.02M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $9.01M derived: sum of 2 quarters · filed 2020-03-27 | $15.01M derived: sum of 3 quarters · filed 2020-03-27 | $18.01M 10-K · filed 2020-03-27 | |||
| 2018-09-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $12.00M derived: sum of 2 quarters · filed 2019-11-08 | $15.00M 10-Q · filed 2019-11-08 | $22.98M derived: sum of 4 quarters · filed 2019-11-08 | |||
| 2018-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $9.00M 10-Q · filed 2019-08-08 | $16.99M derived: sum of 3 quarters · filed 2019-08-08 | $21.99M derived: sum of 4 quarters · filed 2019-08-08 | |||
| 2018-03-31 | $3.00M 10-Q · filed 2019-05-14 | $10.99M derived: sum of 2 quarters · filed 2019-05-14 | $15.98M derived: sum of 3 quarters · filed 2019-05-14 | $17.99M derived: sum of 4 quarters · filed 2019-05-14 | |||
| 2017-12-31 | $7.98M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $12.98M derived: sum of 2 quarters · filed 2019-03-29 | $14.99M derived: sum of 3 quarters · filed 2019-03-29 | $18.99M 10-K · filed 2019-03-29 | |||
| 2017-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $7.01M derived: sum of 2 quarters · filed 2018-11-14 | $11.00M 10-Q · filed 2018-11-14 | $23.99M derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | $2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $6.00M 10-Q · filed 2018-08-13 | $18.99M derived: sum of 3 quarters · filed 2018-08-13 | $21.50M derived: sum of 4 quarters · filed 2018-08-13 | |||
| 2017-03-31 | $4.00M 10-Q · filed 2018-05-14 | $16.98M derived: sum of 2 quarters · filed 2018-05-14 | $19.49M derived: sum of 3 quarters · filed 2018-05-14 | $19.49M derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | $12.99M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $15.49M derived: sum of 2 quarters · filed 2018-03-22 | $15.49M derived: sum of 3 quarters · filed 2018-03-22 | $18.00M 10-K · filed 2018-03-22 | |||
| 2016-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $2.50M derived: sum of 2 quarters · filed 2017-11-14 | $5.01M 10-Q · filed 2017-11-14 | $5.01M derived: sum of 4 quarters · filed 2017-11-14 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $2.51M 10-Q · filed 2017-08-14 | $2.51M derived: sum of 3 quarters · filed 2017-08-14 | $5.01M derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | $2.51M 10-Q · filed 2017-05-15 | $2.51M derived: sum of 2 quarters · filed 2017-05-15 | $5.01M derived: sum of 3 quarters · filed 2017-05-15 | $5.01M derived: sum of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | $2.13K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $2.50M derived: sum of 2 quarters · filed 2017-03-16 | $2.50M derived: sum of 3 quarters · filed 2017-03-16 | $17.99M 10-K · filed 2017-03-16 | |||
| 2015-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $2.50M derived: sum of 2 quarters · filed 2016-11-14 | $17.99M 10-Q · filed 2016-11-14 | $17.99M derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $15.49M 10-Q · filed 2016-08-15 | $15.49M derived: sum of 3 quarters · filed 2016-08-15 | $15.49M derived: sum of 4 quarters · filed 2016-08-15 | |||
| 2015-03-31 | $15.49M 10-Q · filed 2016-05-13 | $15.49M derived: sum of 2 quarters · filed 2016-05-13 | $15.49M derived: sum of 3 quarters · filed 2016-05-13 | $15.26M derived: sum of 4 quarters · filed 2016-05-13 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 derived: sum of 2 quarters · filed 2016-03-30 | -$227.00K derived: sum of 3 quarters · filed 2016-03-30 | $0.00 10-K · filed 2016-03-30 | |||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$227.00K derived: sum of 2 quarters · filed 2015-11-13 | $0.00 10-Q · filed 2015-11-13 | $0.00 derived: sum of 4 quarters · filed 2015-11-13 | |||
| 2014-06-30 | -$227.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $0.00 10-Q · filed 2015-08-14 | $326.92K 10-Q · filed 2014-08-14 | $0.00 derived: sum of 3 quarters · filed 2015-08-14 | $0.00 derived: sum of 4 quarters · filed 2015-08-14 | ||
| 2014-03-31 | $227.00K 10-Q · filed 2015-05-13 | $227.00K derived: sum of 2 quarters · filed 2015-05-13 | $227.00K derived: sum of 3 quarters · filed 2015-05-13 | $411.17K derived: sum of 4 quarters · filed 2015-05-13 | $4.67M 10-Q · filed 2014-05-15 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $184.17K derived: sum of 3 quarters · filed 2015-03-16 | $227.00K 10-K · filed 2015-03-16 | $4.44M 10-K · filed 2014-03-31 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $184.17K derived: sum of 2 quarters · filed 2014-11-14 | $227.00K 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | $184.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $227.00K 10-Q · filed 2014-08-14 | |||||
| 2013-03-31 | $42.83K 10-Q · filed 2014-05-15 | ||||||
| 2012-12-31 | $4.21M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |